Tivozanib Impurity 17 CAS CATO-C4X-340017
| CAS No. | CATO-C4X-340017 |
| Molecular Formula | C17H14ClNO3 |
| Molecular Weight | 315.75 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Tivozanib Impurity 17 is closely related to a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Tivozanib Impurity 17 (CAS CATO-C4X-340017), a pharmacopoeial impurity reference standard (molecular formula C17H14ClNO3, MW 315.75 g/mol) used for the identification and quantification of trace impurities in APIs.
Based on its molecular formula C17H14ClNO3, Tivozanib Impurity 17 contains a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 315.75 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Tivozanib Impurity 17 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C17H14ClNO3 |
| Molecular Weight | 315.75 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 11.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Tivozanib Standards
- Tivozanib Impurity 4 (CAS CATO-C4X-34004)
- Tivozanib Impurity 6 (CAS CATO-C4X-34006)
- Tivozanib Impurity 29 (CAS CATO-C4X-340029)
- Tivozanib Impurity 3 (CAS CATO-C4X-34003)
- Tivozanib Impurity 5 (CAS CATO-C4X-34005)
- Tivozanib Impurity 2 (CAS CATO-C4X-34002)
- Tivozanib Impurity 7 (CAS CATO-C4X-34007)
- Tivozanib Impurity 9 (CAS 1808274-21-6)
Recommended Standards
- Asenapine Impurity 5 (CAS CATO-C4X-19475)
- 3-Chloro-6-(6-methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridin-2-yl)-4-methylpyridazine (CAS 1914990-50-3)
- Asenapine Impurity 4 (CAS CATO-C4X-19474)
- 3-(4-Chlorophenyl)-7-(piperazin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine (CAS 941868-01-5)
- Doxorubicin Impurity 29 (CAS CATO-C4X-203329)
- Trimebutine Impurity 16 (CAS CATO-C4X-185816)
- Memantine impurity 50 (CAS CATO-C4X-105850)
- 4-Chloro-2-methylacetanilide (CAS 5202-86-8)
- methyl 2-aminothiazolo[4,5-b]pyridine-5-carboxylate (CAS 1206250-57-8)
- N-Hydroxy-3-(3H-imidazo[4,5-b]pyridin-2-yl)benzimidamide (CAS 1256486-26-6)
- 3-(Benzo[d]thiazol-2-yl)-1-methyl-1H-pyrazol-5(4H)-one (CAS 64289-13-0)
- 3-Fluoro-4-(methylthio)benzamide (CAS 238742-81-9)
- 3-Methanesulfonyl-4,6-dimethyl-2-(propane-1-sulfinyl)pyridine (CAS 339016-89-6)
- Tirzepatide Impurity 50 (CAS CATO-C4X-324050)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com